Light-Triggered Biomimetic Nanoerythrocyte for Tumor-Targeted Lung Metastatic Combination Therapy of Malignant Melanoma
- PMID: 30141569
- DOI: 10.1002/smll.201801754
Light-Triggered Biomimetic Nanoerythrocyte for Tumor-Targeted Lung Metastatic Combination Therapy of Malignant Melanoma
Abstract
Red blood cell (RBC) membrane-cloaked nanoparticles, reserving the intact cell membrane structure and membrane protein, can gain excellent cell-specific functions such as long blood circulation and immune escape, providing a promising therapy nanoplatform for drug delivery. Herein, a novel RBC membrane biomimetic combination therapeutic system with tumor targeting ability is constructed by embedding bovine serum albumin (BSA) encapsulated with 1,2-diaminocyclohexane-platinum (II) (DACHPt) and indocyanine green (ICG) in the targeting peptide-modified erythrocyte membrane (R-RBC@BPtI) for enhancing tumor internalization and synergetic chemophototherapy. R-RBC@BPtI displays excellent stability and high encapsulation efficiency with multiple cores enveloped in the membrane. Benefited from the stealth functionality and targeting modification of erythrocyte membranes, R-RBC@BPtI can significantly promote tumor targeting and cellular uptake. Under the near-infrared laser stimuli, R-RBC@BPtI presents remarkable instability by singlet oxygen and heat-mediated cleavage so as to trigger effective drug release, thereby achieving deep penetration and accumulation of DACHPt and ROS in the tumor site. Consequently, R-RBC@BPtI with tumor-specific targeting ability accomplishes remarkable ablation of tumors and suppressed lung metastasis in vivo by photothermal and chemotherapy combined ablation under phototriggering. This research provides a novel strategy of targeted biomimetic nanoplatforms for combined cancer chemotherapy-phototherapy.
Keywords: RBC membrane; biomimetic nanoparticle; chemophototherapy; targeted delivery.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Light/pH-Triggered Biomimetic Red Blood Cell Membranes Camouflaged Small Molecular Drug Assemblies for Imaging-Guided Combinational Chemo-Photothermal Therapy.ACS Appl Mater Interfaces. 2019 May 1;11(17):15262-15275. doi: 10.1021/acsami.9b00897. Epub 2019 Apr 17. ACS Appl Mater Interfaces. 2019. PMID: 30964624
-
Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.Acta Biomater. 2017 Sep 1;59:269-282. doi: 10.1016/j.actbio.2017.06.035. Epub 2017 Jun 27. Acta Biomater. 2017. PMID: 28663143
-
Worm-Like Biomimetic Nanoerythrocyte Carrying siRNA for Melanoma Gene Therapy.Small. 2018 Nov;14(47):e1803002. doi: 10.1002/smll.201803002. Epub 2018 Oct 17. Small. 2018. PMID: 30334353
-
Cell membrane-based biomimetic technology for cancer phototherapy: Mechanisms, recent advances and perspectives.Acta Biomater. 2024 Jan 15;174:26-48. doi: 10.1016/j.actbio.2023.11.029. Epub 2023 Nov 25. Acta Biomater. 2024. PMID: 38008198 Review.
-
The potential of biomimetic nanoparticles for tumor-targeted drug delivery.Nanomedicine (Lond). 2018 Aug;13(16):2099-2118. doi: 10.2217/nnm-2018-0017. Epub 2018 Sep 18. Nanomedicine (Lond). 2018. PMID: 30226404 Review.
Cited by
-
Exploring the Microfluidic Production of Biomimetic Hybrid Nanoparticles and Their Pharmaceutical Applications.Pharmaceutics. 2023 Jul 14;15(7):1953. doi: 10.3390/pharmaceutics15071953. Pharmaceutics. 2023. PMID: 37514139 Free PMC article. Review.
-
Chronicles of Nanoerythrosomes: An Erythrocyte-Based Biomimetic Smart Drug Delivery System as a Therapeutic and Diagnostic Tool in Cancer Therapy.Pharmaceutics. 2021 Mar 10;13(3):368. doi: 10.3390/pharmaceutics13030368. Pharmaceutics. 2021. PMID: 33802156 Free PMC article. Review.
-
Recent progress in targeted delivery vectors based on biomimetic nanoparticles.Signal Transduct Target Ther. 2021 Jun 7;6(1):225. doi: 10.1038/s41392-021-00631-2. Signal Transduct Target Ther. 2021. PMID: 34099630 Free PMC article. Review.
-
Targeted delivery of a PROTAC induced PDEδ degrader by a biomimetic drug delivery system for enhanced cytotoxicity against pancreatic cancer cells.Am J Cancer Res. 2022 Mar 15;12(3):1027-1041. eCollection 2022. Am J Cancer Res. 2022. PMID: 35411249 Free PMC article.
-
Advanced biomimetic nanoreactor for specifically killing tumor cells through multi-enzyme cascade.Theranostics. 2020 May 15;10(14):6245-6260. doi: 10.7150/thno.45456. eCollection 2020. Theranostics. 2020. PMID: 32483451 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources